Skip to content
Search

Latest Stories

Court to hear a continuation appeal in Nirav Modi case in June

A BRITISH high court will hear a continuation appeal in the extradition case of Nirav Modi, the fugitive diamond merchant wanted in India to face charges of fraud and money laundering, in London on June 28.

Modi is accused defrauding Punjab National Bank (PNB), one of the India’s largest banks, of $1.8 billion. The 51-year-old diamond merchant had lodged an appeal against his extradition order on mental health grounds.


“The hearing is listed for the 28th June,” the Royal Courts of Justice administrative office confirmed last week.

Lord Justice Jeremy Stuart-Smith and Justice Robert Jay presided over an initial hearing at the court in December last year to determine whether district judge Sam Goozee's Westminster Magistrates' Court ruling from February 2021 in favour of extradition was incorrect to overlook the diamond merchant's “high risk of suicide”.

The hearing in June is for a continuation of that appeal.

According to officials familiar with the case, the Indian government has given assurances about the conditions in which Modi will be detained if he is extradited to India where facilities will be available to care for his “physical and mental health”.

At the June hearing, both sides will make submissions on whether those assurances are sufficient and can be relied upon.

“He is at high risk of suicide already and his condition is likely to deteriorate further in Mumbai,” Edward Fitzgerald QC had argued on behalf of Modi during an appeal hearing in December.

Modi remains behind bars at Wandsworth Prison in south-west London since his arrest in March 2019.

He is the subject of two sets of criminal proceedings, with a Central Bureau of Investigation (CBI) case relating to a large-scale fraud upon PNB through the fraudulent obtaining of letters of undertaking (LoUs) or loan agreements.

A second Enforcement Directorate (ED) case relates to the laundering of the proceeds of that fraud.

He also faces two additional charges of "causing the disappearance of evidence" and intimidating witnesses or “criminal intimidation to cause death”, which were added to the CBI case.

Modi's legal team has argued against extraditing him due to his mental condition that they claim could lead to suicidal impulses, given the family history of suicide of his mother, and that he is at risk of “flagrant denial of justice” in India.

His lawyers have also claimed the Covid-19 pandemic is “overwhelming” the Indian prison system.

The Crown Prosecution Service (CPS), arguing on behalf of India, has highlighted the “high level of diplomatic assurance” to provide adequate medical attention to the accused on being extradited to face trial in India.

If Modi wins this appeal hearing in the high court, he cannot be extradited unless the Indian government is successful in getting permission to appeal at the Supreme Court on a point of law of public importance.

If he loses this appeal hearing, Modi can approach the Supreme Court on a point of law of public importance, to be applied for to the Supreme Court against the high court's decision within 14 days of a high court verdict.

After all the avenues in the UK courts are exhausted, the diamantaire could still seek a so-called Rule 39 injunction from the European Court of Human Rights.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less